Market Overview

Walgreen's Shares Moving Up Following Barclays Upgrade

Related WAG
UPDATE: Walgreens Boots Alliance Filing Shows Prelim. Proxy Statement Related to Strategic Transaction
Will Rite Aid (RAD) Miss Estimates this Earnings Season?
Will the Prez Call Out…The Oracle? (Fox Business)

In a note released Wednesday, Barclays analyst Meredith Alder upgraded shares of Walgreen Co. (NYSE: WAG) from Equal-weight to Overweight and increased her price target form $56 to $92.

The $36 increase to the price target represents 26 percent upside to the closing price on June 16.

The upgrade comes amid criticisms from vocal shareholders, which Alder believes the board is beginning to consider. Alder noted the board is now looking at potential changes, including reducing expenses and optimizing the capital structure, that could "materially boost" earnings and share price.

In a forward outlook, Alder is forecasting an EPS in fiscal 2016 of $5.51, which is 11 percent above consensus estimates.

Following the release of this note, Walgreen's shares have traded up approximately three percent to ~$75.25.

Latest Ratings for WAG

Sep 2014BarclaysDowngradesOverweightEqual-weight
Aug 2014Bank of AmericaUpgradesUnderperformNeutral
Aug 2014Cantor FitzgeraldUpgradesSellHold

View More Analyst Ratings for WAG
View the Latest Analyst Ratings

Posted-In: Barclays Meredith AlderAnalyst Color News Upgrades Price Target Analyst Ratings


Related Articles (WAG)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters